Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
  • 1. Prevention
  • 2. Screening
  • 3. Diagnosis
  • 4. Treatment
  • 5. Person-Centred Perspective
  • 6. Research
  • 7. Appropriateness
  • 8. Long-term outcomes
  • Smoking prevalence
  • Smoking behaviours in current cancer patients
  • Smoking cessation
  • Second-hand smoke exposure
  • Geographic variation in lung cancer risk
  • Alcohol consumption
  • Adult overweight and obesity
  • Active transportation
  • Physical inactivity
  • Human papillomavirus (HPV) vaccination
  • Fruit and vegetable consumption
  • Geographic variation in colorectal cancer risk
  • Cervical cancer screening
  • Breast cancer screening
  • Colorectal cancer screening
  • PSA testing
  • Screening in underserved populations
  • Breast cancer diagnosis wait times
  • Colorectal cancer diagnosis wait times
  • Capture of stage
  • Stage distribution
  • Prostate risk profile
  • Surgery
  • Radiation therapy
  • Systemic therapy
  • Removal and examination of 12 or more lymph nodes in colon resections
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
  • The use of breast-conserving surgery versus mastectomies for breast cancer resections
  • Breast cancer resections that are mastectomies
  • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
  • Prostate wait times for surgery
  • Radical prostatectomy: open versus laparoscopic surgery
  • Radiation therapy wait times
  • Radiation therapy utilization and capacity
  • Pre-operative radiation therapy for patients with stage II or III rectal cancer
  • Post-operative radiation therapy for patients with stage I or II breast cancer
  • Prostate wait times for radiation therapy
  • Prostate patterns of care: radiation and surgical treatment
  • Post-operative chemotherapy for stage III colon cancer patients
  • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
  • Screening for distress
  • Patient satisfaction
  • Place of death
  • Prostate access to palliative radiation
  • Adult clinical trial participation
  • Prostate clinical trials participation
  • Pediatric clinical trial participation
  • Cancer research investment
  • Prostate cancer research investment
  • Breast cancer screening outside of guidelines
  • Breast cancer mastectomies done as day surgery
  • Intensive care use in the last two weeks of life
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Five-year net survival by income quintile for several cancers in Canada
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Cancer control domain
  • 5. Person-Centred Perspective
  • Place of death

Place of death

  • Charts and Tables

    Charts and Tables

    Figure 5.3

    Percentage of cancer patient deaths occurring in hospital, private home or other places, by jurisdiction — 2013 reporting year

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    SK: Owing to small numbers, deaths in private homes were combined with Other.

    TR: Territories combined.

    Provinces and territories vary in how location of death is categorized and the classification of different settings. In Manitoba, for example, many deaths categorized as in-hospital occur in palliative care units or hospital-based hospices.

    The percentage might not sum up to 100% due to rounding.

    Data source: Statistics Canada: Vital Statistics Death Database.

    Data Table

    JurisdictionPlace of deathNumber of deaths due to cancerPercent (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    BCHospital4,69048.647.649.6
    BCPrivate home1,54016.015.216.7
    BCOther3,42535.534.536.4
    ABHospital3,97564.363.165.5
    ABPrivate home72511.710.912.6
    ABOther1,48023.922.925.0
    SKHospital1,53065.863.867.7
    SKPrivate home****
    SKOther79534.232.336.2
    MBHospital2,36587.886.589.0
    MBPrivate home29010.89.612.0
    MBOther401.51.12.0
    ONHospital16,97061.560.962.1
    ONPrivate home5,86021.220.821.7
    ONOther4,77017.316.817.7
    QCHospital15,22075.574.976.1
    QCPrivate home1,6958.48.08.8
    QCOther3,24016.115.616.6
    NBHospital1,47077.275.279.0
    NBPrivate home24512.911.414.4
    NBOther19010.08.711.4
    NSHospital1,82570.168.371.8
    NSPrivate home58022.320.723.9
    NSOther2007.76.78.8
    PEHospital23062.257.067.1
    PEPrivate home4512.29.015.9
    PEOther9525.721.330.4
    NLHospital1,15579.176.981.2
    NLPrivate home16011.09.412.7
    NLOther1459.98.411.6
    TRHospital9054.546.662.3
    TRPrivate home4024.217.931.5
    TROther3521.215.228.2

    + Expand Table

    SK: Owing to small numbers, deaths in private homes were combined with Other.

    TR: Territories combined.

    Provinces and territories vary in how location of death is categorized and the classification of different settings. In Manitoba, for example, many deaths categorized as in-hospital occur in palliative care units or hospital-based hospices.

    The percentage might not sum up to 100% due to rounding.

    Data source: Statistics Canada: Vital Statistics Death Database.

  • Data specifications

    Data specifications

    Definition: The percentage of cancer patients who died in hospital, private home and other places

    Rationale for measurement: Measuring place of death, although a crude measure, addresses one important aspect of end-of-life care and may contribute to better planning and quality of end-of-life care for cancer patients.

    Measurement timeframe: Year 2013

    Denominator: Number of deaths due to any invasive cancers

    Numerator: Number of deaths due to any invasive cancers grouped into 3 locations:

    • hospital
    • private home
    • other places

    Exclusion criteria: Not applicable

    Data availability: All provinces and territories

    Stratification: By jurisdiction (territories were combined)

    Data source: Statistics Canada, Vital Statistics Death Database

    Data retrieval date: October 2017

    Variables details: Not applicable

    Notes from jurisdictions:

    • QC: “Hospital” includes residential and long-term care centres.
    • MB: Designated palliative care units were included in “Hospital.” In other provinces this type of bed may be considered part of long-term care (“Other”).
    • SK: A very small proportion of deaths were recorded as private home, so that private home and other were combined together.

    Methodology notes:

    1. Data were retrieved from Vital Statistics Death Databases.
    2. Data presented include ages 0+, provinces/territories combined
    3. The percentages of place of death were based on random rounded counts using Statistics Canada algorithm.
    4. The definition of hospital varied across provinces. Hospices can be classified as “Other” or “Hospital” depending on province.
    5. “Other” included other specified locality, other health care facility, private home and unknown localities.

    Changes to definition compared to previous years: Not applicable

  • Related indicators

    Related Indicators

    Intensive care use in the last two weeks of life

    Percentage of cancer patients dying in an acute-care hospital and admitted to intensive care units in the last 14 days of life, by jurisdiction — 2014/15 and 2015/16 fiscal years combined
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow’s Health
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation